Long-term results of hepatic resection combined with intraoperative local ablation therapy for patients with multinodular hepatocellular carcinomas

Annals of Surgical Oncology

Volumn 16, Issue 12, 2009, Pages 3299-3307

  Itoh, Shinji ^a,b   Morita, Kazutoyo ^a   Ueda, Shigeru ^a   Sugimachi, Keishi ^a   Yamashita, Yo Ichi ^a   Gion, Tomonobu ^a   Fukuzawa, Kengo ^b   Wakasugi, Kenzo ^b   Taketomi, Akinobu ^a   Maehara, Yoshihiko ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b OITA RED CROSS HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DECARBOXYPROTHROMBIN;

ADULT; AGED; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; MICROWAVE THERAPY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; RADIOFREQUENCY ABLATION; SCLEROTHERAPY;

CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; FEMALE; FOLLOW-UP STUDIES; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; SURVIVAL RATE; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 71549126218     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-009-0721-0     Document Type: Article

References (41)

1. M Shimada K Takenaka Y Fujiwara, et al. 1998 Risk factors linked to postoperative morbidity in patients with hepatocellular carcinoma Br J Surg. 85 195 198 10.1046/j.1365-2168.1998.00567.x 1:STN:280:DyaK1c7mt1Cgtw%3D%3D 9501814 (Pubitemid 28099936)
2. A Taketomi D Kitagawa S Itoh, et al. 2007 Trends in morbidity and mortality after hepatic resection for hepatocellular carcinoma: an institute's experience with 625 patients J Am Coll Surg 204 4 580 587 10.1016/j.jamcollsurg. 2007.01.035 17382216 (Pubitemid 46428578)
3. K Takenaka N Kawahara K Yamamoto, et al. 1996 Results of 280 liver resections for hepatocellular carcinoma Arch Surg. 131 71 76 1:STN:280:DyaK287ktVWktg%3D%3D 8546582
4. Y-I Yamashita A Taketomi S Itoh, et al. 2007 Longterm Favorable Results of Limited Hepatic Resections for Patients with Hepatocellular Carcinoma J Am Coll Surg 205 1 19 26 10.1016/j.jamcollsurg.2007.01.069 17617328 (Pubitemid 47016949)
5. Liver Cancer Study Group of Japan 1980 Primary liver cancers in Japan Cancer. 45 2663 2669 10.1002/1097-0142(19800515)45:10<2663::AID- CNCR2820451030>3.0.CO;2-G
6. EC Lai ST Fan CM Lo, et al. 1995 Hepatic resection for hepatocellular carcinoma: an audit of 343 patients Ann Surg. 221 291 298 10.1097/00000658- 199503000-00012 1:STN:280:DyaK2M3jtlygtA%3D%3D 7717783
7. S Todo H Furukawa 2004 Living donor liver transplantation for adult patients with hepatocellular carcinoma. Experience in Japan Ann Surg. 240 451 461 10.1097/01.sla.0000137129.98894.42 15319716 (Pubitemid 39121339)
8. A Taketomi Y Soejima T Yoshizumi, et al. 2008 Liver transplantation for hepatocellular carcinoma J Hepatobiliary Pancreat Surg. 15 124 130 10.1007/s00534-007-1296-4 18392704
9. M Kudo 2004 Local ablation therapy for hepatocellular carcinoma: current status and future prospectives J Gastroenterol 39 3 205 214 10.1007/s00535-003- 1280-y 15064996 (Pubitemid 38519424)
10. M Sala JM Llovet R Vilana, et al. 2004 Initial response to percutaneous ablation predicts survival in patients with hepatocellular carcinoma Hepatology. 40 1352 1360 10.1002/hep.20465 15565564 (Pubitemid 39657009)
11. C Coinaud 1954 Lobes et segments hepatiques Press Med. 62 709 712
12. M Shimada K Takenaka K Taguchi, et al. 1998 Prognostic factors after repeat hepatectomy for recurrent hepatocellular carcinoma Ann Surg. 227 80 85 10.1097/00000658-199801000-00012 1:STN:280:DyaK1c7gsFymuw%3D%3D 9445114 (Pubitemid 28071341)
13. T Kanematsu T Furuta K Takenaka, et al. 1989 A 5-year experience of lipiodolization: selective regional chemotherapy for 200 patients with hepatocellular carcinoma Hepatology. 10 98 102 10.1002/hep.1840100119 1:STN:280:DyaL1M3ptVKqtA%3D%3D 2544499
14. S Itoh A Taketomi S Tanaka, et al. 2007 Role of growth factor receptor-bound protein 7 in hepatocellular carcinoma Mol Cancer Res. 5 667 673 10.1158/1541-7786.MCR-06-0282 1:CAS:528:DC%2BD2sXnvVChtL4%3D 17634422
15. V Mazzafero E Regalia R Doci, et al. 1996 Liver transplantation for treatment of small hepatocellular carcinomas in patients with cirrhosis N Engl J Med. 14 728
16. HA Edmondson PE Steiner 1954 Primary carcinoma of the liver: a study of 100 cases among 48, 900 necropsies Cancer. 7 462 503 10.1002/1097-0142(195405)7: 3<462::AID-CNCR2820070308>3.0.CO;2-E 1:STN:280:DyaG2c%2FotV2mtQ%3D%3D 13160935
17. S Itoh T Maeda M Shimada, et al. 2004 Role of expression of focal adhesion kinase in progression of hepatocellular carcinoma Clin Cancer Res. 10 2812 2817 10.1158/1078-0432.CCR-1046-03 1:CAS:528:DC%2BD2cXjt1CltbY%3D 15102689 (Pubitemid 38509160)
18. R Tateishi S Shiina T Teratani, et al. 2005 Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1000 cases Cancer 103 1201 1209 10.1002/cncr.20892 15690326 (Pubitemid 40328091)
19. T Seki M Wakabayashi T Nakagawa, et al. 1999 Percutaneous microwave coagulation therapy for patients with small hepatocellular carcinoma: comparison with percutaneous ethanol injection therapy Cancer. 85 1694 1702 10.1002/(SICI)1097-0142(19990415)85:8<1694::AID-CNCR8>3.0.CO;2-3 1:STN:280:DyaK1M3jvVSksQ%3D%3D 10223562 (Pubitemid 29169669)
20. R Santambrogio E Opocher M Costa, et al. 2005 Survival and intra-hepatic recurrences after laparoscopic radiofrequency of hepatocellular carcinoma in patients with cirrhosis J Surg Oncol. 89 218 225 10.1002/jso.20204 15726623 (Pubitemid 40333527)
21. C Kawamoto K Ido N Isoda, et al. 2005 Long-term outcomes for patients with solitary hepatocellular carcinoma treated by laparoscopic microwave coagulation Cancer. 103 985 993 10.1002/cncr.20880 15672389 (Pubitemid 40270075)
22. CP Raut F Izzo P Marra, et al. 2005 Significant long-term survival after radiofrequency ablation of unresectable hepatocellular carcinoma in patients with cirrhosis Ann Surg Oncol. 12 616 628 10.1245/ASO.2005.06.011 15965731 (Pubitemid 41126091)
23. D Choi HK Lim JW Joh, et al. 2007 Combined hepatectomy and radiofrequency ablation for multifocal hepatocellular carcinomas: long-term follow-up results and prognostic factors Ann Surg Oncol. 14 3510 3518 10.1245/s10434-007-9492-7 17653800 (Pubitemid 350160100)
24. Y Fong RL Sun W Jarnagin, et al. 1999 An analysis of 412 cases of hepatocellular carcinoma at a Western center Ann Surg. 229 790 800 10.1097/00000658-199906000-00005 1:STN:280:DyaK1M3ptVGlsg%3D%3D 10363892 (Pubitemid 30191728)
25. S Arii Y Yamaoka S Futagawa, et al. 2000 Results of surgical and nonsurgical treatment for small-size hepatocellular carcinomas: a retrospective and nationwide survey in Japan. The Liver Cancer Study Group of Japan Hepatology. 32 1224 1229 10.1053/jhep.2000.20456 1:STN:280: DC%2BD3M%2FntFegsQ%3D%3D 11093728
26. T Livraghi L Bolondi L Buscarini, et al. 1995 No treatment, resection and ethanol injection in hepatocellular carcinoma: a retrospective analysis of survival in 391 patients with cirrhosis. Italian Cooperative HCC Study Group J Hepatol. 22 522 526 10.1016/0168-8278(95)80445-5 1:STN:280:DyaK2MznvVKitg%3D%3D 7650331
27. K Urata T Matsumata T Kamakura, et al. 1994 Lipiodolization for unresectable hepatocellular carcinoma: An analysis of 205 patients using univariate and multivariate analysis J Surg Oncol. 56 54 58 10.1002/jso. 2930560113 1:STN:280:DyaK2c3jtFOqsA%3D%3D 8176943
28. The Liver Cancer Study Group of Japan. The general rules for clinical and pathological study of primary liver cancer, 4th ed. Tokyo: Kanehara; 2000.
29. M Vivarelli A Guglielmi A Ruzzenente, et al. 2004 Surgical resection versus percutaneous radiofrequency ablation in the treatment of hepatocellular carcinoma on cirrhotic liver Ann Surg. 240 102 107 10.1097/01.sla.0000129672. 51886.44 15213625 (Pubitemid 38808241)
30. T Wakai Y Shirai T Suda, et al. 2006 Long-term outcomes of hepatectomy vs percutaneous ablation for treatment of hepatocellular carcinoma >4 cm World J Gastroenterol. 12 546 552 16489666
31. M Makuuchi H Hasegawa S Yamazaki, et al. 1987 The use of operative ultrasound as an aid to liver resection in patients with hepatocellular carcinoma World J Surg. 11 615 621 10.1007/BF01655837 1:STN:280: DyaL1c%2FksVyiug%3D%3D 2823489
32. CL Scaife CS Ng LM Ellis, et al. 2006 Accuracy of preoperative imaging of hepatic tumors with helical computed tomography Ann Surg Oncol. 13 542 546 10.1245/ASO.2006.07.009 16474907
33. The Liver Cancer Study Group of Japan 1994 Predictive factors for long-term prognosis after partial hepatectomy for patients with hepatocellular carcinoma in Japan Cancer. 74 2772 2780 10.1002/1097-0142(19941115)74: 10<2772::AID-CNCR2820741006>3.0.CO;2-V (Pubitemid 24340543)
34. M Shimada Y Yamashita T Hamatsu, et al. 2000 The role of des-gamma-carboxy prothrombin levels in hepatocellular carcinoma and liver tissues Cancer Lett. 159 87 94 10.1016/S0304-3835(00)00539-5 1:CAS:528:DC%2BD3cXmtF2qu74%3D 10974410 (Pubitemid 30676218)
35. JA Marrero GL Su W Wei, et al. 2003 Des-gamma carboxyprothrombin can differentiate hepatocellular carcinoma from nonmalignant chronic liver disease in American patients Hepatology. 37 1114 1121 10.1053/jhep.2003.50195 1:CAS:528:DC%2BD3sXktVWnsLs%3D 12717392 (Pubitemid 36538688)
36. M Shimada K Takenaka Y Fujiwara, et al. 1996 Des-gamma-carboxy prothrombin and alpha-fetoprotein positive status as a new prognostic indicator after hepatic resection for hepatocellular carcinoma Cancer. 78 2094 2100 10.1002/(SICI)1097-0142(19961115)78:10<2094::AID-CNCR9>3.0.CO;2-O 1:STN:280:DyaK2s%2Fns1Skuw%3D%3D 8918402 (Pubitemid 26367601)
37. K Shirabe S Itoh T Yoshizumi, et al. 2007 The predictors of microvascular invasion in candidates for liver transplantation with hepatocellular carcinoma-with special reference to the serum levels of des-gamma-carboxy prothrombin J Surg Oncol. 95 235 240 10.1002/jso.20655 1:CAS:528: DC%2BD2sXjvVSjsrg%3D 17323337 (Pubitemid 46310016)
38. Y Koike Y Shiratori S Sato, et al. 2001 Des-gamma-carboxy prothrombin as a useful predisposing factor for the development of portal venous invasion in patients with hepatocellular carcinoma: a prospective analysis of 227 patients Cancer. 91 561 569 10.1002/1097-0142(20010201)91:3<561::AID-CNCR1035>3.0. CO;2-N 1:CAS:528:DC%2BD3MXhtVKjsLk%3D 11169939 (Pubitemid 32105702)
39. Y Soejima A Taketomi T Yoshizumi, et al. 2007 Extended indication for living donor liver transplantation in patients with hepatocellular carcinoma Transplantation. 83 893 899 10.1097/01.tp.0000259015.46798.ec 17460559 (Pubitemid 46682729)
40. A Taketomi K Sanefuji Y Soejima, et al. 2009 Impact of des-gamma-carboxy prothrombin and tumor size on the recurrence of hepatocellular carcinoma after living donor liver transplantation Transplantation. 87 531 537 10.1097/TP.0b013e3181943d46 19307789
41. T Ito Y Takada M Ueda, et al. 2007 Expansion of selection criteria for patients with hepatocellular carcinoma in living donor liver transplantation Liver Transpl. 13 1637 1644 10.1002/lt.21281 18044766